Burrill on Biotech What Lies Ahead for Biotech in 2008

摘要

Although it will be slow in the first quarter, 2008 will turn out to be a good year for biotech, especially in the second half. The initiatives that are now in place will continue to drive the industry towards a personalized healthcare world-one that emphasizes earlier disease detection, more targeted treatments, and adjunctive support through enhanced nutrition.